AT-II-receptor antagonists include losartan, valsartan, irbesartan, candesartan, eprosartan, telmisartan, and tasosartan. Several clinical trials have demonstrated that AT-II-receptor antagonists ...

More than 12 million bottles of blood pressure-lowering drugs such as valsartan and losartan have been removed from the market since 2018 because they contained nitrosamines.

Six ARBs are currently available in the United States for hypertension: losartan, valsartan, irbesartan, candesartan, eprosartan, and telmisartan (Table 1). All ARBs share certain features because ...

According to the most recent data, the daily cost of 20 mg of benazepril in the US is 5, 13 and 71 times lower than those of similarly antiproteinuric doses of losartan (100 mg), valsartan (320 mg ...